Stockreport

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference

Cardiff Oncology, Inc.  (CRDF) 
PDF SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel [Read more]